Bristol-Myers Squibb
(NYSE:BMY)
$51.95
-0.39[-0.75%]
At close: Mar 18
$51.95
0[0.00%]
After Hours: 7:27PM EDT

GET A REPORT ON BMY SENT RIGHT TO YOUR INBOX

Bristol-Myers Squibb Stock (NYSE:BMY), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Neutral
Highest Price Target1
$90.00
Lowest Price Target1
$50.00
Consensus Price Target1
$56.24

Analyst Rating Summary1

Analyst Ratings
Oct 23
3
4
2
Nov 23
2
Dec 23
1
Jan
1
Feb
2
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wells Fargo
Redburn Atlantic
B of A Securities
Cantor Fitzgerald
Deutsche Bank

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Bristol-Myers Squibb

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/06/2024BMYBuy Now
Bristol-Myers Squibb
$51.95-1.83%Wells Fargo
Mohit Bansal
$58 → $51MaintainsEqual-WeightGet Alert
02/06/2024BMYBuy Now
Bristol-Myers Squibb
$51.953.95%Redburn Atlantic
Steve Chesney
$77 → $54DowngradeBuy → NeutralGet Alert
01/03/2024BMYBuy Now
Bristol-Myers Squibb
$51.9515.5%B of A Securities
Geoff Meacham
$68 → $60DowngradeBuy → NeutralGet Alert
12/27/2023BMYBuy Now
Bristol-Myers Squibb
$51.9530.9%B of A Securities
Geoff Meacham
$72 → $68MaintainsBuyGet Alert
11/15/2023BMYBuy Now
Bristol-Myers Squibb
$51.955.87%Cantor Fitzgerald
Olivia Brayer
$68 → $55DowngradeOverweight → NeutralGet Alert
11/09/2023BMYBuy Now
Bristol-Myers Squibb
$51.955.87%Deutsche Bank
James Shin
→ $55Initiates → HoldGet Alert
11/02/2023BMYBuy Now
Bristol-Myers Squibb
$51.953.95%Daiwa Capital
Narumi Nakagiri
$68 → $54DowngradeOutperform → NeutralGet Alert
10/30/2023BMYBuy Now
Bristol-Myers Squibb
$51.9532.82%Goldman Sachs
Chris Shibutani
$81 → $69MaintainsBuyGet Alert
10/27/2023BMYBuy Now
Bristol-Myers Squibb
$51.95-3.75%Morgan Stanley
Terence Flynn
$56 → $50MaintainsUnderweightGet Alert
10/27/2023BMYBuy Now
Bristol-Myers Squibb
$51.95-1.83%Barclays
Carter Gould
$60 → $51MaintainsEqual-WeightGet Alert
10/27/2023BMYBuy Now
Bristol-Myers Squibb
$51.9515.5%BMO Capital
Evan Seigerman
→ $60DowngradeOutperform → Market PerformGet Alert
10/27/2023BMYBuy Now
Bristol-Myers Squibb
$51.95William Blair
Matt Phipps
DowngradeOutperform → Market PerformGet Alert
10/27/2023BMYBuy Now
Bristol-Myers Squibb
$51.952.02%HSBC
Rajesh Kumar
$55 → $53UpgradeReduce → HoldGet Alert
10/20/2023BMYBuy Now
Bristol-Myers Squibb
$51.9515.5%UBS
Trung Huynh
$70 → $60AssumesNeutral → NeutralGet Alert
10/11/2023BMYBuy Now
Bristol-Myers Squibb
$51.957.8%Morgan Stanley
Terence Flynn
$57 → $56MaintainsUnderweightGet Alert
10/09/2023BMYBuy Now
Bristol-Myers Squibb
$51.9544.37%Cantor Fitzgerald
Olivia Brayer
→ $75ReiteratesOverweight → OverweightGet Alert
10/06/2023BMYBuy Now
Bristol-Myers Squibb
$51.9561.69%Truist Securities
Robyn Karnauskas
→ $84ReiteratesBuy → BuyGet Alert
09/15/2023BMYBuy Now
Bristol-Myers Squibb
$51.9561.69%Truist Securities
Gregg Gilbert
→ $84ReiteratesBuy → BuyGet Alert
09/15/2023BMYBuy Now
Bristol-Myers Squibb
$51.9527.05%TD Cowen
Steve Scala
$80 → $66MaintainsMarket PerformGet Alert

FAQ

Q

What is the target price for Bristol-Myers Squibb (BMY)?

A

The latest price target for Bristol-Myers Squibb (NYSE: BMY) was reported by Wells Fargo on February 6, 2024. The analyst firm set a price target for $51.00 expecting BMY to fall to within 12 months (a possible -1.83% downside). 35 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Bristol-Myers Squibb (BMY)?

A

The latest analyst rating for Bristol-Myers Squibb (NYSE: BMY) was provided by Wells Fargo, and Bristol-Myers Squibb maintained their equal-weight rating.

Q

When is the next analyst rating going to be posted or updated for Bristol-Myers Squibb (BMY)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bristol-Myers Squibb, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bristol-Myers Squibb was filed on February 6, 2024 so you should expect the next rating to be made available sometime around February 6, 2025.

Q

Is the Analyst Rating Bristol-Myers Squibb (BMY) correct?

A

While ratings are subjective and will change, the latest Bristol-Myers Squibb (BMY) rating was a maintained with a price target of $58.00 to $51.00. The current price Bristol-Myers Squibb (BMY) is trading at is $51.95, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch